ARTICLE | Distillery Therapeutics
Neurology
May 30, 2018 6:51 PM UTC
In silico, in vitro, cell culture and Drosophila studies identified a small molecule targeting SMN2 mRNA that could help treat SMA by increasing levels of full length SMN2 to partially compensate for ...
BCIQ Target Profiles